Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers

DSpace Repositorium (Manakin basiert)

Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers

Autor(en): Dannehl, Dominik; Engler, Tobias; Volmer, Lea Louise; Tegeler, Christian Martin; Fusshoeller, Julia; Gabrysch, Emma; Eissler, Kenneth; Seller, Anna; Grischke, Eva-Maria; Hahn, Markus; Gruber, Ines; Schochter, Fabienne; Pfister, Kerstin; Veselinovic, Kristina; Leinert, Elena; Rack, Brigitte; Fink, Visnja; Janni, Wolfgang; Brucker, Sara Yvonne; Hartkopf, Andreas Daniel; Schaeffler, Henning
Tübinger Autor(en):
Dannehl, Dominik
Engler, Tobias
Fusshoeller, Julia
Gabrysch, Emma
Eissler, Kenneth
Seller, Anna
Grischke, Eva-Maria
Hahn, Markus
Gruber, Ines
Volmer, Léa
Tegeler, Christian M.
Brucker, Sara
Hartkopf, Andreas
Erschienen in: Cancers (2023), Bd. 15 (15), Article 3847
Verlagsangabe: Basel : Mdpi
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.3390/cancers15153847
ISSN: 2072-6694
DDC-Klassifikation: 610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: